ArticleEBioMedicine2018

IgM anti-malondialdehyde low density lipoprotein antibody levels indicate coronary heart disease and necrotic core characteristics in the Nordic Diltiazem (NORDIL) study and the Integrated Imaging and Biomarker Study 3 (IBIS-3).

Victor J van den Berg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.